Siteworks GmbH
- Address
- lock Available on a paid plan
Respiratory and Sleep-Related Disorders
At Siteworks GmbH in Hanover, a strong share of the research focuses on respiratory tract diseases and sleep-related conditions. The studies include asthma, chronic obstructive pulmonary disease, refractory chronic cough, and obstructive sleep apnea, with the aim of improving symptom control, lung function, breathing-related outcomes, and overall quality of life.
- Testing new approaches for inadequately controlled asthma and severe asthma
- Evaluating treatments for COPD and reducing exacerbations
- Studying therapies for obstructive sleep apnea linked to overweight or obesity
- Assessing options for chronic cough and nasal allergy symptoms
This area of research is centered on finding better ways to manage long-term breathing disorders and sleep disturbances.
Pain, Musculoskeletal, and Metabolic Research
Another major theme at the site is the study of pain disorders, musculoskeletal diseases, and nutritional and metabolic diseases. Trials are looking at diabetic peripheral neuropathic pain, knee osteoarthritis, chronic low back pain, hypercholesterolemia, obesity, and related conditions, with the goal of easing pain, supporting mobility, and improving metabolic health.
- Exploring new therapies for neuropathic pain and osteoarthritis
- Evaluating treatments for overweight and obesity with related health risks
- Studying options that may improve cholesterol and cardiovascular risk factors
- Assessing relief strategies for chronic back pain and joint pain
The research reflects a broader effort to address conditions that commonly affect daily function and long-term health.
Cardiovascular, Kidney, and Blood Pressure Studies
The site also conducts trials in cardiovascular diseases and kidney-related conditions, especially where blood pressure control and heart protection are important. Current research includes uncontrolled hypertension, resistant hypertension, chronic kidney disease, and prevention of heart failure, with studies designed to evaluate better treatment effectiveness and long-term outcomes.
- Investigating therapies for high blood pressure that remains difficult to control
- Assessing approaches for chronic kidney disease linked with hypertension
- Studying prevention of heart failure and cardiovascular complications
- Comparing treatments to improve LDL cholesterol and cardiovascular risk
These studies aim to support better management of conditions that can lead to serious heart and kidney complications.
Skin, Allergy, and Immune-Mediated Conditions
A notable part of the portfolio addresses skin and connective tissue diseases and immune system diseases. Research at the site includes atopic dermatitis, plaque psoriasis, chronic spontaneous urticaria, perennial allergic rhinitis, and female androgenetic alopecia, focusing on symptom reduction, disease control, and improved patient comfort.
- Testing new treatments for psoriasis and atopic dermatitis
- Evaluating therapies for urticaria and allergic rhinitis
- Studying options for hair loss in women
- Assessing immune-targeted therapies for persistent inflammatory conditions
This work reflects a strong interest in conditions driven by inflammation, allergy, and immune dysregulation.
Digestive, Hormonal, and Mental Health Research
The remaining studies cover digestive system diseases, hormonal diseases, and mental disorders. Trials include irritable bowel syndrome, diarrhoea-predominant IBS, sleep disturbances associated with menopause, insomnia disorder, and major depressive disorder, with the purpose of improving symptoms, supporting sleep, and evaluating overall treatment benefit.
- Assessing therapies for IBS and diarrhoea-predominant IBS
- Studying treatments for menopause-related sleep problems and insomnia
- Evaluating options for mild to moderate depression
- Testing supportive approaches for digestive comfort and symptom relief
Together, these studies show a broad interest in conditions that affect sleep, mood, and gastrointestinal health.
Viral and Preventive Medicine
Virus diseases are represented through research on influenza, where the focus is on preventive care and protection against infection. These studies are designed to assess vaccine effectiveness and safety, contributing to better seasonal disease prevention.
- Evaluating an influenza vaccine for protection against common viral strains
- Studying safety and immune response in preventive research
This adds a public-health-oriented dimension to the broader clinical trial program at the site.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 12 therapeutic areas and 15 of 52 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 51 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1AstraZeneca AB4active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB8trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Siteworks GmbH
lock Showing 1 of 36 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Double Blind, Multicentre, Randomised Three-Period, Three-Treatment, Cross-Over Study To Evaluate The Effect of BGF MDI, BFF MDI and Placebo MDI on Exercise Parameters In Participants with Chronic Obstructive Pulmonary Disease (ATHLOS) | AstraZeneca AB | Phase I | Not Recruiting | Oct 2023 | Jan 2026 |
IMP list
lock Showing 1 of 52 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Budesonide | 4 | Unknown | 2021-04-25 | 2024-07-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
